An official website of the United States government
NIH Guide: Weekly Index for August 4, 2023
Weekly NIH Guide Notices
August 4, 2023
Policy Notices
-
NIH Application Instruction Updates Data Management and Sharing (DMS) Costs
(NOT-OD-23-161)National Institutes of Health
General Notices
-
Notice of Participation of the National Institute on Aging (NIA) in PAR-23-219, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)"
(NOT-AG-23-047)National Institute on Aging
-
Notice of Participation of the National Institute on Aging (NIA) in PAR-23-220, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)"
(NOT-AG-23-048)National Institute on Aging
-
Notice of NCIs Participation in RFA-OD-23-018 ADVANCE Predoctoral T32 Training Program to Promote Diversity in Health Disparities Research, Preventive Interventions, and Methodology (T32, Clinical Trial Not Allowed)
(NOT-CA-23-082)National Cancer Institute
-
Notice of Research Opportunity Announcements for the HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW): Addressing Overdose, Substance Use, Mental Health, and Pain Program
(NOT-DA-23-030)National Institute on Drug AbuseNational Institute on Alcohol Abuse and Alcoholism
-
NIDCR Notice of Participation in PAR-23-109, NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
(NOT-DE-23-014)National Institute of Dental and Craniofacial Research
Notice of Changes to Funding Opportunities
-
Notice to Update Part 2, Sections I, III, and IV - Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Acute Low Back Pain (U01) Clinical Trials Not Allowed
(NOT-FD-23-012)Food and Drug Administration
-
Notice to Update Part 2, Sections I, III, and IV - Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Laparoscopic Abdominal Surgeries (U01) Clinical Trials Not Allowed
(NOT-FD-23-013)Food and Drug Administration
-
Notice of Change to Extend Last Receipt Date for NINDS Innovation Grants to Nurture Initial Translational Efforts (IGNITE) PAR-21-122, PAR-21-123 and PAR-21-124 (R61/R33 Clinical Trial Not Allowed)
(NOT-NS-23-095)National Institute of Neurological Disorders and Stroke
-
Notice of NINDS Participation in PAR-23-109 "NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)"
(NOT-NS-23-102)National Institute of Neurological Disorders and StrokeNational Institute of Allergy and Infectious Diseases
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for High-Priority Behavioral and Social Research Networks??(R24 Clinical Trial Optional)
(NOT-AG-23-044)National Institute on Aging
-
Notice of Intent to Publish a Funding Opportunity Announcement for Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
(NOT-DC-23-015)National Institute on Deafness and Other Communication Disorders
-
Notice of Intent to Publish a Funding Opportunity Announcement for Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
(NOT-DC-23-016)National Institute on Deafness and Other Communication Disorders
Notices of Special Interest
-
Notice of Special Interest (NOSI): Administrative Supplement for Accelerating Research in Understudied Skin Types
(NOT-AR-24-008)National Institute of Arthritis and Musculoskeletal and Skin Diseases
-
Notice of Special Interest (NOSI): Accelerating Research in Understudied Skin Types
(NOT-AR-24-009)National Institute of Arthritis and Musculoskeletal and Skin Diseases
-
Notice of Special Interest (NOSI): Supporting Recovery-Oriented, Family-Centered Care for Pregnant, Postpartum, and Parenting Women with Opioid Use Disorder
(NOT-DA-24-008)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): HEAL Initiative: Leveraging Inpatient Medical or Surgical Hospitalizations to Improve Outcomes for People Who Use Drugs
(NOT-DA-24-011)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Role of social function on SUD treatment and outcomes
(NOT-DA-25-026)National Institute on Drug Abuse
-
Notice of Special Interest (NOSI): Maternal Health and the Dental, Oral, and Craniofacial Development of their Children
(NOT-DE-23-005)National Institute of Dental and Craniofacial Research
Funding Opportunities
-
Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed)
(PAR-23-240)National Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseApplication Receipt Date(s): May 25, 2026
-
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
(PAR-23-248)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): September 26, 2025
-
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
(PAR-23-254)National Cancer InstituteNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Human Genome Research InstituteApplication Receipt Date(s): November 17, 2024
-
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
(PAR-23-255)National Cancer InstituteNational Institute on AgingNational Institute of Dental and Craniofacial ResearchNational Human Genome Research InstituteApplication Receipt Date(s): May 23, 2025
-
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
(RFA-DA-25-001)National Institute on Drug AbuseApplication Receipt Date(s): August 14, 2024
-
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
(RFA-DA-25-002)National Institute on Drug AbuseApplication Receipt Date(s): August 14, 2024
-
A Consortium for Gut-Brain Communication in Parkinsons Disease (U01 Clinical Trial Not Allowed)
(RFA-DK-22-036)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): November 15, 2023
-
A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed)
(RFA-DK-23-001)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): November 15, 2023
-
Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATCH-IN) Implementation Science Coordinating Center (UM2 Clinical Trial Optional)
(RFA-HD-24-009)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentJohn E. Fogarty International CenterApplication Receipt Date(s): December 6, 2023
-
Network of Genomics-Enabled Learning Health Systems (gLHS) Clinical Sites (U01 Clinical Trial Required)
(RFA-HG-23-041)National Human Genome Research InstituteApplication Receipt Date(s): November 7, 2023
-
Network of Genomics-Enabled Learning Health Systems (gLHS) Coordinating Center (U01 Clinical Trials Required)
(RFA-HG-23-042)National Human Genome Research InstituteApplication Receipt Date(s): November 7, 2023
-
Validating digital health technologies for monitoring biomarkers in ADRD clinical trials (R61/R33 - Clinical Trials Optional)
(RFA-NS-24-026)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): November 17, 2023
-
Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required)
(RFA-OD-23-021)Office of Disease PreventionNational Cancer InstituteApplication Receipt Date(s): December 6, 2023
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster